We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

544 hedge funds and large institutions have $2.01B invested in iShares US Medical Devices ETF in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 152 increasing their positions, 224 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $12.7M

3.75% more ownership

Funds ownership: 35.74%39.49% (+3.8%)

7% less funds holding

Funds holding: 585544 (-41)

8% less capital invested

Capital invested by funds: $2.19B → $2.01B (-$185M)

32% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 224

40% less funds holding in top 10

Funds holding in top 10: 159 (-6)

46% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 80

Holders
544
Holders Change
-41
Holders Change %
-7.01%
% of All Funds
8.63%
Holding in Top 10
9
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-40%
% of All Funds
0.14%
New
43
Increased
152
Reduced
224
Closed
80
Calls
$18.6M
Puts
$12.7M
Net Calls
+$5.93M
Net Calls Change
+$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
PWW
301
Pettyjohn Wood & White
Virginia
$447K
GWSG
302
GPS Wealth Strategies Group
Colorado
$444K -$13.1K -246 -3%
JCM
303
Jacobi Capital Management
Pennsylvania
$443K -$1.54K -29 -0.3%
BSG
304
Black Swift Group
Colorado
$441K +$484K +9,100 New
KDA
305
Kraft Davis & Associates
Missouri
$441K -$181K -3,395 -27%
VWM
306
Venturi Wealth Management
Texas
$441K -$377K -7,082 -44%
PTC
307
Private Trust Company
Ohio
$427K +$23.6K +444 +5%
PWA
308
Physician Wealth Advisors
Utah
$426K +$16.8K +316 +4%
GLA
309
Good Life Advisors
Pennsylvania
$421K -$167K -3,132 -27%
Koshinski Asset Management
310
Koshinski Asset Management
Illinois
$417K +$2.82K +53 +0.6%
PWM
311
Perigon Wealth Management
California
$415K +$11.4K +214 +3%
SAM
312
Secure Asset Management
Michigan
$415K +$2.66K +50 +0.6%
HFP
313
Holistic Financial Partners
Indiana
$412K -$12.6K -237 -3%
CWM
314
Comprehensive Wealth Management
Washington
$412K +$22K +414 +5%
SIC
315
Sterling Investment Counsel
New York
$411K +$5.74K +108 +1%
HFRG
316
Houlihan Financial Resource Group
Virginia
$411K +$463K +8,700 New
RWMH
317
Riverpoint Wealth Management Holdings
Illinois
$407K
BBA
318
BLB&B Advisors
Pennsylvania
$405K -$267K -5,016 -38%
SEIA
319
Signature Estate & Investment Advisors
California
$397K -$49.8K -936 -10%
PCM
320
Penserra Capital Management
California
$395K +$434K +8,160 New
PWA
321
PCG Wealth Advisors
Kansas
$394K -$1.22K -23 -0.3%
AL
322
Aspiriant LLC
California
$394K
WP
323
WealthSource Partners
California
$385K -$67.3K -1,266 -14%
GEA
324
Glen Eagle Advisors
New Jersey
$380K
ACM
325
Advisors Capital Management
New Jersey
$379K +$40.4K +759 +11%

IHI Hedge Fund Activity: Q3 2023 in Review

544 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q3 2023, worth a combined $2.01B — down 8.4% from $2.19B a quarter earlier.

Sellers outnumbered buyers: 80 funds closed out of IHI and 43 opened new positions — a net loss of 37 holders — while 224 trimmed existing stakes and 152 added.

The largest buyer was Bank of America, adding an estimated $50.2M. The largest seller was Morgan Stanley, cutting an estimated $34.4M.

  • 544 institutional investors held iShares US Medical Devices ETF (IHI) as of Q3 2023, down from 585 in Q2 2023.
  • Funds reported $2.01B of iShares US Medical Devices ETF stock for Q3 2023, down 8.4% quarter-over-quarter.
  • 43 funds opened new iShares US Medical Devices ETF positions in Q3 2023 and 80 closed out, a net change of -37 holders.
  • The largest iShares US Medical Devices ETF buyer in Q3 2023 was Bank of America, an estimated $50.2M added.
  • The largest iShares US Medical Devices ETF seller in Q3 2023 was Morgan Stanley, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2023.